Cargando…
Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial
BACKGROUND: Chronic kidney disease is associated with increased arterial stiffness even in the early stages and this is thought to be a key mediator in the pathophysiology of the increased cardiovascular risk associated with this condition. The use of low-dose spironolactone has previously been show...
Autores principales: | Ng, Khai P, Jain, Poorva, Heer, Gurdip, Redman, Val, Chagoury, Odette L, Dowswell, George, Greenfield, Sheila, Freemantle, Nick, Townend, Jonathan N, Gill, Paramjit S, McManus, Richard J, Ferro, Charles J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113230/ https://www.ncbi.nlm.nih.gov/pubmed/24886272 http://dx.doi.org/10.1186/1745-6215-15-158 |
Ejemplares similares
-
Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial
por: Ng, Khai P, et al.
Publicado: (2016) -
Blood pressure in different ethnic groups (BP-Eth): a mixed methods study
por: Wood, Sally, et al.
Publicado: (2012) -
Measurement of blood pressure for the diagnosis and management of hypertension in different ethnic groups: one size fits all
por: Gill, Paramjit, et al.
Publicado: (2017) -
Influence of ethnicity on acceptability of method of blood pressure monitoring: a cross-sectional study in primary care
por: Wood, Sally, et al.
Publicado: (2016) -
Interarm Difference in Systolic Blood Pressure in Different Ethnic Groups and Relationship to the “White Coat Effect”: A Cross-Sectional Study
por: Schwartz, Claire Lorraine, et al.
Publicado: (2017)